{"pmid":32275287,"title":"COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population.","text":["COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population.","Since the beginning of the COVID-19 epidemic in Italy, the Italian Government implemented several restrictive measures to contain the spread of the infection. Data shows that, among these measures, the lockdown implemented as of 9 March had a positive impact, in particular the central and southern regions of Italy, while other actions appeared to be less effective. When the true prevalence of a disease is unknown, it is possible estimate it, based on mortality data and the assumptive case-fatality rate of the disease. Given these assumptions, the estimated period-prevalence of COVID-19 in Italy varies from 0.35% in Sicity to 13.3% in Lombardy.","Acta Biomed","Signorelli, Carlo","Scognamiglio, Thea","Odone, Anna","32275287"],"abstract":["Since the beginning of the COVID-19 epidemic in Italy, the Italian Government implemented several restrictive measures to contain the spread of the infection. Data shows that, among these measures, the lockdown implemented as of 9 March had a positive impact, in particular the central and southern regions of Italy, while other actions appeared to be less effective. When the true prevalence of a disease is unknown, it is possible estimate it, based on mortality data and the assumptive case-fatality rate of the disease. Given these assumptions, the estimated period-prevalence of COVID-19 in Italy varies from 0.35% in Sicity to 13.3% in Lombardy."],"journal":"Acta Biomed","authors":["Signorelli, Carlo","Scognamiglio, Thea","Odone, Anna"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275287","week":"202015|Apr 06 - Apr 12","doi":"10.23750/abm.v91i3-S.9511","source":"PubMed","locations":["Italy","Italy","Italy","Lombardy","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Epidemic Forecasting","Prevention"],"weight":1,"_version_":1663712077910376448,"score":7.9164424,"similar":[{"pmid":32265115,"title":"COVID-19 in Colombia endpoints. Are we different, like Europe?","text":["COVID-19 in Colombia endpoints. Are we different, like Europe?","The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the limited capacity of the health system to respond effectively to the needs of patients infected. For Colombia, assuming a case fatality rate among people infected with SARS-CoV-2 of 0.6% (average data from the information reported for Latin American countries for March 18) (Table 1), the number of deaths, in one or two weeks, could be 16 and 243, respectively. These estimates differ markedly from those documented in countries such as Spain and Italy, in which COVID-19 case fatality rates exceed 8% (case of Italy) and from the percentage of patients who have required intensive care, which has ranged from 9% to 11% of patients in Mediterranean European countries. These differences could be explained due to: a) the percentage of the population at risk (individuals older than 60 years); b) a higher epidemiological exposure to viral respiratory infections associated with more frequent exposure to them, due to geographic and climatic conditions; c) less spread of the virus by location in the tropical zone; and d) earlier preventive measures to contain the spread of SARS-CoV-2 infection. Therefore, it is possible to establish that the situation in this country will be different from in European Mediterranean and that Colombia could have different endpoints from Spain and Italy.","Res Social Adm Pharm","Amariles, Pedro","Granados, Johan","Ceballos, Mauricio","Montoya, Carlos Julio","32265115"],"abstract":["The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the limited capacity of the health system to respond effectively to the needs of patients infected. For Colombia, assuming a case fatality rate among people infected with SARS-CoV-2 of 0.6% (average data from the information reported for Latin American countries for March 18) (Table 1), the number of deaths, in one or two weeks, could be 16 and 243, respectively. These estimates differ markedly from those documented in countries such as Spain and Italy, in which COVID-19 case fatality rates exceed 8% (case of Italy) and from the percentage of patients who have required intensive care, which has ranged from 9% to 11% of patients in Mediterranean European countries. These differences could be explained due to: a) the percentage of the population at risk (individuals older than 60 years); b) a higher epidemiological exposure to viral respiratory infections associated with more frequent exposure to them, due to geographic and climatic conditions; c) less spread of the virus by location in the tropical zone; and d) earlier preventive measures to contain the spread of SARS-CoV-2 infection. Therefore, it is possible to establish that the situation in this country will be different from in European Mediterranean and that Colombia could have different endpoints from Spain and Italy."],"journal":"Res Social Adm Pharm","authors":["Amariles, Pedro","Granados, Johan","Ceballos, Mauricio","Montoya, Carlos Julio"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265115","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.sapharm.2020.03.013","source":"PubMed","locations":["Latin American","Spain","Italy","Colombia"],"countries":["Italy","Spain","Colombia"],"countries_codes":["ITA|Italy","ESP|Spain","COL|Colombia"],"topics":["Epidemic Forecasting","Prevention"],"weight":1,"_version_":1663609715781795842,"score":230.08542},{"pmid":32099934,"pmcid":"PMC7029158","title":"An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov).","text":["An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov).","The basic reproduction number of an infectious agent is the average number of infections one case can generate over the course of the infectious period, in a naive, uninfected population. It is well-known that the estimation of this number may vary due to several methodological issues, including different assumptions and choice of parameters, utilized models, used datasets and estimation period. With the spreading of the novel coronavirus (2019-nCoV) infection, the reproduction number has been found to vary, reflecting the dynamics of transmission of the coronavirus outbreak as well as the case reporting rate. Due to significant variations in the control strategies, which have been changing over time, and thanks to the introduction of detection technologies that have been rapidly improved, enabling to shorten the time from infection/symptoms onset to diagnosis, leading to faster confirmation of the new coronavirus cases, our previous estimations on the transmission risk of the 2019-nCoV need to be revised. By using time-dependent contact and diagnose rates, we refit our previously proposed dynamics transmission model to the data available until January 29th(,) 2020 and re-estimated the effective daily reproduction ratio that better quantifies the evolution of the interventions. We estimated when the effective daily reproduction ratio has fallen below 1 and when the epidemics will peak. Our updated findings suggest that the best measure is persistent and strict self-isolation. The epidemics will continue to grow, and can peak soon with the peak time depending highly on the public health interventions practically implemented.","Infect Dis Model","Tang, Biao","Bragazzi, Nicola Luigi","Li, Qian","Tang, Sanyi","Xiao, Yanni","Wu, Jianhong","32099934"],"abstract":["The basic reproduction number of an infectious agent is the average number of infections one case can generate over the course of the infectious period, in a naive, uninfected population. It is well-known that the estimation of this number may vary due to several methodological issues, including different assumptions and choice of parameters, utilized models, used datasets and estimation period. With the spreading of the novel coronavirus (2019-nCoV) infection, the reproduction number has been found to vary, reflecting the dynamics of transmission of the coronavirus outbreak as well as the case reporting rate. Due to significant variations in the control strategies, which have been changing over time, and thanks to the introduction of detection technologies that have been rapidly improved, enabling to shorten the time from infection/symptoms onset to diagnosis, leading to faster confirmation of the new coronavirus cases, our previous estimations on the transmission risk of the 2019-nCoV need to be revised. By using time-dependent contact and diagnose rates, we refit our previously proposed dynamics transmission model to the data available until January 29th(,) 2020 and re-estimated the effective daily reproduction ratio that better quantifies the evolution of the interventions. We estimated when the effective daily reproduction ratio has fallen below 1 and when the epidemics will peak. Our updated findings suggest that the best measure is persistent and strict self-isolation. The epidemics will continue to grow, and can peak soon with the peak time depending highly on the public health interventions practically implemented."],"journal":"Infect Dis Model","authors":["Tang, Biao","Bragazzi, Nicola Luigi","Li, Qian","Tang, Sanyi","Xiao, Yanni","Wu, Jianhong"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32099934","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.idm.2020.02.001","keywords":["Basic reproduction number","Effective daily reproduction ratio","Emerging and reemerging pathogens","Mathematical modeling","Novel coronavirus"],"source":"PubMed","topics":["Epidemic Forecasting","Prevention","Transmission"],"weight":1,"_version_":1663352134473613313,"score":227.83858},{"pmid":32133152,"pmcid":"PMC7039910","title":"Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China.","text":["Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China.","An outbreak of clusters of viral pneumonia due to a novel coronavirus (2019-nCoV/SARS-CoV-2) happened in Wuhan, Hubei Province in China in December 2019. Since the outbreak, several groups reported estimated R 0 of Coronavirus Disease 2019 (COVID-19) and generated valuable prediction for the early phase of this outbreak. After implementation of strict prevention and control measures in China, new estimation is needed. An infectious disease dynamics SEIR (Susceptible, Exposed, Infectious, and Removed) model was applied to estimate the epidemic trend in Wuhan, China under two assumptions of R t . In the first assumption, R t was assumed to maintain over 1. The estimated number of infections would continue to increase throughout February without any indication of dropping with R t = 1.9, 2.6, or 3.1. The number of infections would reach 11,044, 70,258, and 227,989, respectively, by 29 February 2020. In the second assumption, R t was assumed to gradually decrease at different phases from high level of transmission (R t = 3.1, 2.6, and 1.9) to below 1 (R t = 0.9 or 0.5) owing to increasingly implemented public health intervention. Several phases were divided by the dates when various levels of prevention and control measures were taken in effect in Wuhan. The estimated number of infections would reach the peak in late February, which is 58,077-84,520 or 55,869-81,393. Whether or not the peak of the number of infections would occur in February 2020 may be an important index for evaluating the sufficiency of the current measures taken in China. Regardless of the occurrence of the peak, the currently strict measures in Wuhan should be continuously implemented and necessary strict public health measures should be applied in other locations in China with high number of COVID-19 cases, in order to reduce R t to an ideal level and control the infection.","Cell Discov","Wang, Huwen","Wang, Zezhou","Dong, Yinqiao","Chang, Ruijie","Xu, Chen","Yu, Xiaoyue","Zhang, Shuxian","Tsamlag, Lhakpa","Shang, Meili","Huang, Jinyan","Wang, Ying","Xu, Gang","Shen, Tian","Zhang, Xinxin","Cai, Yong","32133152"],"abstract":["An outbreak of clusters of viral pneumonia due to a novel coronavirus (2019-nCoV/SARS-CoV-2) happened in Wuhan, Hubei Province in China in December 2019. Since the outbreak, several groups reported estimated R 0 of Coronavirus Disease 2019 (COVID-19) and generated valuable prediction for the early phase of this outbreak. After implementation of strict prevention and control measures in China, new estimation is needed. An infectious disease dynamics SEIR (Susceptible, Exposed, Infectious, and Removed) model was applied to estimate the epidemic trend in Wuhan, China under two assumptions of R t . In the first assumption, R t was assumed to maintain over 1. The estimated number of infections would continue to increase throughout February without any indication of dropping with R t = 1.9, 2.6, or 3.1. The number of infections would reach 11,044, 70,258, and 227,989, respectively, by 29 February 2020. In the second assumption, R t was assumed to gradually decrease at different phases from high level of transmission (R t = 3.1, 2.6, and 1.9) to below 1 (R t = 0.9 or 0.5) owing to increasingly implemented public health intervention. Several phases were divided by the dates when various levels of prevention and control measures were taken in effect in Wuhan. The estimated number of infections would reach the peak in late February, which is 58,077-84,520 or 55,869-81,393. Whether or not the peak of the number of infections would occur in February 2020 may be an important index for evaluating the sufficiency of the current measures taken in China. Regardless of the occurrence of the peak, the currently strict measures in Wuhan should be continuously implemented and necessary strict public health measures should be applied in other locations in China with high number of COVID-19 cases, in order to reduce R t to an ideal level and control the infection."],"journal":"Cell Discov","authors":["Wang, Huwen","Wang, Zezhou","Dong, Yinqiao","Chang, Ruijie","Xu, Chen","Yu, Xiaoyue","Zhang, Shuxian","Tsamlag, Lhakpa","Shang, Meili","Huang, Jinyan","Wang, Ying","Xu, Gang","Shen, Tian","Zhang, Xinxin","Cai, Yong"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32133152","week":"202010|Mar 02 - Mar 08","doi":"10.1038/s41421-020-0148-0","keywords":["Autoimmunity","Immunology"],"source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting","Prevention"],"weight":1,"_version_":1663352134234537984,"score":220.84311},{"pmid":32235086,"title":"As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.","text":["As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.","COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARS-CoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities.","J Infect Dev Ctries","Rubino, Salvatore","Kelvin, Nikki","Bermejo-Martin, Jesus F","Kelvin, David","32235086"],"abstract":["COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARS-CoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities."],"journal":"J Infect Dev Ctries","authors":["Rubino, Salvatore","Kelvin, Nikki","Bermejo-Martin, Jesus F","Kelvin, David"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235086","week":"202014|Mar 30 - Apr 05","doi":"10.3855/jidc.12734","keywords":["*COVID-19","*Case Fatality Rates","*Immunity","*Italy","*Novel coronavirus","*SARS-CoV-19"],"source":"PubMed","locations":["Italy","China"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1663352135543160834,"score":211.0949},{"pmid":32234343,"pmcid":"PMC7102547","title":"Monitoring Transmissibility and Mortality of COVID-19 in Europe.","text":["Monitoring Transmissibility and Mortality of COVID-19 in Europe.","OBJECTIVES: As a global pandemic is inevitable, real-time monitoring of transmission is vital for containing the spread of COVID-19. The main objective was to report real-time effective reproduction numbers (R(t)) case fatality rate (CFR). METHODS: Data were mainly obtained from WHO website, up to 9 March 2020. R(t) was estimated by exponential growth rate (EG) and time dependent (TD) methods. \"R0\" package in R was employed to estimate R(t) by fitting the existing epidemic curve. Both naive CFR (nCFR) and adjust CFR (aCFR) were estimated. RESULTS: In EG method, R(t) was 3.27 [3.17-3.38] for Italy, 6.32 [5.72-6.99] for France, 6.07 [5.51-6.69] for Germany, 5.08 [4.51-5.74] for Spain. With TD method, the R value for March 9 was 3.10 [2.21-4.11] for Italy, 6.56 [2.04-12.26] for France, 4.43 [1.83-7.92] for Germany, and 3.95 [0-10.19] for Spain. CONCLUSIONS: This study provides important findings on an early outbreak of COVID-19 in Europe. Due to the recent rapid increase in new cases of COVID-19, real-time monitoring of the transmissibility and mortality in Spain and France is a priority.","Int J Infect Dis","Yuan, Jing","Li, Minghui","Lv, Gang","Lu, Z Kevin","32234343"],"abstract":["OBJECTIVES: As a global pandemic is inevitable, real-time monitoring of transmission is vital for containing the spread of COVID-19. The main objective was to report real-time effective reproduction numbers (R(t)) case fatality rate (CFR). METHODS: Data were mainly obtained from WHO website, up to 9 March 2020. R(t) was estimated by exponential growth rate (EG) and time dependent (TD) methods. \"R0\" package in R was employed to estimate R(t) by fitting the existing epidemic curve. Both naive CFR (nCFR) and adjust CFR (aCFR) were estimated. RESULTS: In EG method, R(t) was 3.27 [3.17-3.38] for Italy, 6.32 [5.72-6.99] for France, 6.07 [5.51-6.69] for Germany, 5.08 [4.51-5.74] for Spain. With TD method, the R value for March 9 was 3.10 [2.21-4.11] for Italy, 6.56 [2.04-12.26] for France, 4.43 [1.83-7.92] for Germany, and 3.95 [0-10.19] for Spain. CONCLUSIONS: This study provides important findings on an early outbreak of COVID-19 in Europe. Due to the recent rapid increase in new cases of COVID-19, real-time monitoring of the transmissibility and mortality in Spain and France is a priority."],"journal":"Int J Infect Dis","authors":["Yuan, Jing","Li, Minghui","Lv, Gang","Lu, Z Kevin"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234343","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijid.2020.03.050","keywords":["COVID-19","Control","Europe","effective reproduction numbers"],"source":"PubMed","locations":["Germany","Italy","France","Spain"],"countries":["France","Italy","Germany","Spain"],"countries_codes":["FRA|France","ITA|Italy","DEU|Germany","ESP|Spain"],"topics":["Epidemic Forecasting","Transmission","Prevention"],"weight":1,"_version_":1663352135632289792,"score":189.02611}]}